Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.56 |
| ▸ | MEN1 | O00255 | 4/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | APEX1 | P27695 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | RECQL | P46063 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | BCL2 | P10415 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | DAPK1 | P53355 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dioncoquinone B SCHEMBL3401149 | 0.80 | MEN1 (0.60) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL2772226 | 0.77 | MAPT (0.86) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL6904748 | 0.75 | MAPT (0.83) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL19449186 | 0.75 | MAPT (0.53) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL29359549 | 0.74 | ELANE (0.70) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL30432375 | 0.74 | ELANE (0.70) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL10909836 | 0.74 | ELANE (0.70) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL13239416 | 0.74 | MAPT (0.68) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL9628613 | 0.73 | CDC25A (0.62) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| Athraquinones A SCHEMBL18614 | 0.72 | MAPT (1.00) | MAPTMEN1KMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115192501-B | Cosmetic composition for protecting skin comprising extracts of rice, reed, corn silk, mallow and aloe | DJFC株式会社 | 2024-04-09 | — | — | CN | disclosed |
| CN-115192501-A | Cosmetic composition for skin protection comprising extracts of rice, reed, corn silk, malva sylvestris and aloe vera | 有限公司丹鼎生物 | 2022-10-18 | — | — | CN | disclosed |
| US-9938308-B2 | Coordination compounds having redox non-innocent ligands and flow batteries containing the same | LOCKHEED MARTIN ENERGY, LLC (US) | 2018-04-10 | — | — | US | disclosed |
| US-20170291916-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ENERGY, LLC | 2017-10-12 | — | — | US | disclosed |
| WO-2017176296-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ADVANCED ENERGY STORAGE, LLC (US) | 2017-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170291916-A1 | COORDINATION COMPOUNDS HAVING REDOX NON-INNOCENT LIGANDS AND FLOW BATTERIES CONTAINING THE SAME | NQO1, VDAC1, SQOR | MAPT 2504/4885MEN1 1349/4885KMT2A 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.